Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Amylin Pharmaceuticals, LLC.. Recruitment status was Active, not recruiting
Study NCT00819234
Information provided by Amylin Pharmaceuticals, LLC.
First Received on December 24, 2008.
Last Updated on January 7, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
